These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 15737846)
1. Detection of B-RAF and N-RAS mutations in human melanoma. Goydos JS; Mann B; Kim HJ; Gabriel EM; Alsina J; Germino FJ; Shih W; Gorski DH J Am Coll Surg; 2005 Mar; 200(3):362-70. PubMed ID: 15737846 [TBL] [Abstract][Full Text] [Related]
2. Detection of mutations in the mitogen-activated protein kinase pathway in human melanoma. Alsina J; Gorsk DH; Germino FJ; Shih W; Lu SE; Zhang ZG; Yang JM; Hait WN; Goydos JS Clin Cancer Res; 2003 Dec; 9(17):6419-25. PubMed ID: 14695143 [TBL] [Abstract][Full Text] [Related]
3. Preponderance of the oncogenic V599E and V599K mutations in B-raf kinase domain is enhanced in melanoma cutaneous/subcutaneous metastases. Deichmann M; Thome M; Benner A; Kirschner M; Hassanzadeh J; Kurzen H BMC Cancer; 2005 Jun; 5():58. PubMed ID: 15935100 [TBL] [Abstract][Full Text] [Related]
4. Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines. Bloethner S; Chen B; Hemminki K; Müller-Berghaus J; Ugurel S; Schadendorf D; Kumar R Carcinogenesis; 2005 Jul; 26(7):1224-32. PubMed ID: 15760917 [TBL] [Abstract][Full Text] [Related]
5. B-raf and Ha-ras mutations in chemically induced mouse liver tumors. Jaworski M; Buchmann A; Bauer P; Riess O; Schwarz M Oncogene; 2005 Feb; 24(7):1290-5. PubMed ID: 15592514 [TBL] [Abstract][Full Text] [Related]
6. Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma. van Elsas A; Zerp SF; van der Flier S; Krüse KM; Aarnoudse C; Hayward NK; Ruiter DJ; Schrier PI Am J Pathol; 1996 Sep; 149(3):883-93. PubMed ID: 8780392 [TBL] [Abstract][Full Text] [Related]
7. Are all melanomas the same? Spitzoid melanoma is a distinct subtype of melanoma. Lee DA; Cohen JA; Twaddell WS; Palacios G; Gill M; Levit E; Halperin AJ; Mones J; Busam KJ; Silvers DN; Celebi JT Cancer; 2006 Feb; 106(4):907-13. PubMed ID: 16421887 [TBL] [Abstract][Full Text] [Related]
8. Genetic similarities between Spitz nevus and Spitzoid melanoma in children. Gill M; Cohen J; Renwick N; Mones JM; Silvers DN; Celebi JT Cancer; 2004 Dec; 101(11):2636-40. PubMed ID: 15503312 [TBL] [Abstract][Full Text] [Related]
9. B-raf exon 15 mutations are common in primary melanoma resection specimens but not associated with clinical outcome. Deichmann M; Thome M; Benner A; Näher H Oncology; 2004; 66(5):411-9. PubMed ID: 15331929 [TBL] [Abstract][Full Text] [Related]
11. NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing. Edlundh-Rose E; Egyházi S; Omholt K; Månsson-Brahme E; Platz A; Hansson J; Lundeberg J Melanoma Res; 2006 Dec; 16(6):471-8. PubMed ID: 17119447 [TBL] [Abstract][Full Text] [Related]
12. Expression status and mutational analysis of the ras and B-raf genes in ovarian granulosa cell and epithelial tumors. Jamieson S; Alexiadis M; Fuller PJ Gynecol Oncol; 2004 Dec; 95(3):603-9. PubMed ID: 15581971 [TBL] [Abstract][Full Text] [Related]
13. The oncogenic B-raf V599E mutation occurs more frequently in melanomas at sun-protected body sites. Deichmann M; Krahl D; Thome M; Wüst K; Hassanzadeh J; Helmke B Int J Oncol; 2006 Jul; 29(1):139-45. PubMed ID: 16773193 [TBL] [Abstract][Full Text] [Related]
14. Human melanoma cells expressing V600E B-RAF are susceptible to IGF1R targeting by small interfering RNAs. Yeh AH; Bohula EA; Macaulay VM Oncogene; 2006 Oct; 25(50):6574-81. PubMed ID: 16715137 [TBL] [Abstract][Full Text] [Related]
15. Mutant V599EB-Raf regulates growth and vascular development of malignant melanoma tumors. Sharma A; Trivedi NR; Zimmerman MA; Tuveson DA; Smith CD; Robertson GP Cancer Res; 2005 Mar; 65(6):2412-21. PubMed ID: 15781657 [TBL] [Abstract][Full Text] [Related]
16. Polymerase chain reaction/sequencing analysis of ras mutations in paraffin-embedded tissues as compared with 3T3 transfection and polymerase chain reaction/sequencing of frozen tumor deoxyribonucleic acids. Goodrow TL; Prahalada SR; Storer RD; Manam SV; Leander KR; Kraynak AR; van Zwieten MJ; Nichols WW; Bradley MO Lab Invest; 1992 Apr; 66(4):504-11. PubMed ID: 1583889 [TBL] [Abstract][Full Text] [Related]
17. Pyrophosphorolysis detects B-RAF mutations in primary uveal melanoma. Maat W; Kilic E; Luyten GP; de Klein A; Jager MJ; Gruis NA; Van der Velden PA Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):23-7. PubMed ID: 18172070 [TBL] [Abstract][Full Text] [Related]
18. [MAP-Kinase pathway abnormalities in melanoma: B-RAF is not the sole cause]. Dereure O Ann Dermatol Venereol; 2012 Oct; 139(10):691-2. PubMed ID: 23122387 [No Abstract] [Full Text] [Related]
19. Low prevalence of RAS-RAF-activating mutations in Spitz melanocytic nevi compared with other melanocytic lesions. Indsto JO; Kumar S; Wang L; Crotty KA; Arbuckle SM; Mann GJ J Cutan Pathol; 2007 Jun; 34(6):448-55. PubMed ID: 17518771 [TBL] [Abstract][Full Text] [Related]
20. Analysis of BRAF and N-RAS mutations in metastatic melanoma tissues. Gorden A; Osman I; Gai W; He D; Huang W; Davidson A; Houghton AN; Busam K; Polsky D Cancer Res; 2003 Jul; 63(14):3955-7. PubMed ID: 12873990 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]